Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Open-Label Trial of Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals With Mild COVID-19

NCT05271929 is registered in ClinicalTrials.gov with Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen as lead sponsor.

NCT NCT05271929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05271929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Open-Label Trial of Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals With Mild COVID-19
Lead sponsor
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen
Phase
Phase 3
Overall status
Terminated
Start date
April 1, 2022
Completion date
June 17, 2024
Enrollment
120 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19